Cost-effectiveness of polysaccharide pneumococcal vaccination in people aged 65 and above in Poland. [electronic resource]
- Human vaccines & immunotherapeutics Oct 2012
- 1382-94 p. digital
Publication Type: Journal Article
2164-554X
10.4161/hv.21571 doi
Aged Aged, 80 and over Cost-Benefit Analysis--methods Female Hospitalization--economics Humans Male Pneumococcal Infections--economics Pneumococcal Vaccines--economics Poland Quality-Adjusted Life Years